Tag: Teva Pharmaceutical Stock

Business

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and Bioeq AG Announce Viable Collaboration for Biosimilar

by 0 comments

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and Bioeq AG today announced that they have arrived into a premeditated Collaboration for the particular commercialization of Bioeq’sBioeq’s FYB201, a biosimilar applicant to Lucentis® in Europe, Canada, Israel, and New Zealand. The agreement comprises commercializing biosimilar applicant of ophthalmology medication ranibizumab  This intentional […]

Continue Reading →
Business

Teva Pharmaceutical Industries Limited (OTCMKTS: TEVA) Announces Approval of AJOVY® Injection in Japan

by 0 comments

Teva Pharmaceutical Industries Limited (OTCMKTS: TEVA) today announced the Ministry of Health, Labor, and Welfare (MHLW) had approved AJOVY injection for the preventive treatment of migraine in grownups in Japan. AJOVY® designed for the deterrent cure of migraine “In Japan is 8.4% of adults are yearly suffereing from migraine. Along […]

Continue Reading →